News Related to Hypocalcemia

Related coverage linked through entity extraction aliases.

FDA Approves Pembrolizumab for Platinum-Resistant Ovarian Cancer

Feb 28, 2026

The FDA approved pembrolizumab in combination with paclitaxel, with or without bevacizumab, for adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma whose tumors express PD-L1 (CPS ≥1).

FDA Approves Denosumab Biosimilars and Issues Hypocalcemia Safety Guidance

Dec 22, 2025

The FDA approved multiple denosumab biosimilars in late 2025 and issued REMS safety updates emphasizing severe hypocalcemia risk in patients with advanced chronic kidney disease, including reported hospitalizations and fatalities.